David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBI
2451
DELISTED
Chicago Bridge & Iron Nv
CBI
| $999K | ﹤0.01% |
59,495
-13,924
| -19% | -$213K |
|
2452
Kforce
KFRC
$1.03B
| $997K | ﹤0.01% |
49,366
+94
| +0.2% | +$1.75K |
|
2453
CALL
Copa Holdings
CPA
$6.04B
| $996K | ﹤0.01% |
+8,000
| New | +$1.01M |
|
|
CPLA
2454
PUT
DELISTED
Capella Education Company
CPLA
| $996K | ﹤0.01% |
14,200
+4,000
| +39% | +$290K |
|
|
ESRX
2455
PUT
DELISTED
Express Scripts Holding Company
ESRX
| $994K | ﹤0.01% |
15,700
-12,700
| -45% | -$789K |
|
|
SRCL
2456
DELISTED
Stericycle Inc
SRCL
| $993K | ﹤0.01% |
13,870
-92,801
| -87% | -$6.83M |
|
2457
Ardmore Shipping
ASC
$735M
| $991K | ﹤0.01% |
120,162
+8,686
| +8% | +$67.4K |
|
2458
Ennis
EBF
$543M
| $986K | ﹤0.01% |
50,190
+9,702
| +24% | +$186K |
|
2459
Lakeland Financial Corp
LKFN
$1.48B
| $985K | ﹤0.01% |
20,213
-2,102
| -9% | -$95K |
|
2460
Woodward
WWD
$20.1B
| $985K | ﹤0.01% |
12,687
-44,481
| -78% | -$3.13M |
|
|
MR
2461
DELISTED
Montage Resources Corporation Common Stock
MR
| $982K | ﹤0.01% |
26,192
-16,353
| -38% | -$614K |
|
2462
Clarus
CLAR
$145M
| $980K | ﹤0.01% |
131,312
-191,041
| -59% | -$1.31M |
|
|
TESO
2463
DELISTED
Tesco Corp
TESO
| $979K | ﹤0.01% |
179,626
+60,739
| +51% | +$279K |
|
2464
Helios Technologies
HLIO
$2.45B
| $976K | ﹤0.01% |
+18,081
| New | +$838K |
|
2465
Renasant Corp
RNST
$3.75B
| $973K | ﹤0.01% |
22,692
+14,661
| +183% | +$604K |
|
|
SIVB
2466
DELISTED
SVB Financial Group
SIVB
| $973K | ﹤0.01% |
5,200
+796
| +18% | +$140K |
|
2467
Silicom
SILC
$249M
| $972K | ﹤0.01% |
16,618
-10,449
| -39% | -$555K |
|
2468
CALL
APA Corp
APA
$14.5B
| $971K | ﹤0.01% |
21,200
+1,200
| +6% | +$52.9K |
|
2469
Southern Copper
SCCO
$186B
| $971K | ﹤0.01% |
26,664
-162,007
| -86% | -$5.79M |
|
2470
Vitamin Cottage Natural Grocers
NGVC
$651M
| $969K | ﹤0.01% |
173,701
+76,415
| +79% | +$511K |
|
2471
Dr. Reddy's Laboratories
RDY
$10.3B
| $969K | ﹤0.01% |
135,750
-710,075
| -84% | -$5.11M |
|
|
STML
2472
DELISTED
Stemline Therapeutics, Inc.
STML
| $969K | ﹤0.01% |
87,294
-14,990
| -15% | -$141K |
|
|
OXFD
2473
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $968K | ﹤0.01% |
57,641
-15,030
| -21% | -$245K |
|
|
SNCR
2474
DELISTED
Synchronoss Technologies
SNCR
| $966K | ﹤0.01% |
11,506
-27,452
| -70% | -$3.82M |
|
2475
CALL
Visteon
VC
$2.77B
| $965K | ﹤0.01% |
+7,800
| New | +$884K |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.